LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Virtual Heart Reveals Important Information on Common Heart Defect

By LabMedica International staff writers
Posted on 06 Feb 2013
Print article
Image: Image from the advanced new 3D virtual heart model. (Photo courtesy of University of Manchester).
Image: Image from the advanced new 3D virtual heart model. (Photo courtesy of University of Manchester).
With advanced computational technology and information, researchers have built a highly accurate 3D model of a mammalian heart, enabling a study that revealed new information about the mechanisms underlying one of the world’s most common heart conditions.

In a collaborative effort led by scientists at the University of Manchester (Manchester, UK), the model was developed by taking a series of very thin slices of a sheep’s heart, imaging them in 2D, then computationally rendering them into a 3D virtual model. The anatomically realistic reconstruction includes details of the complex fiber structure of the tissue, and the segmentation of the upper chambers of the heart into known distinctive regions. Single-cell models that take into account information about the electrical activity in different atrial regions were then incorporated into the model. The virtual heart was then used to investigate the sudden irregular heart-rate condition “atrial fibrillation” (AF), which affects approximately 1.5% of the population worldwide, and is known to increase the risk and severity of stroke, yet very little is known about its cause(s).

The research team focused on the pulmonary vein, a common area that triggers AF. They simulated erratic electrical waves passing through the vein and the surrounding atrial tissue, then studied the impact this had on the rest of the heart. Electrical heterogeneity (regional differences in the electrical activity across the heart tissue) was found to be a key to initiation of AF. The largest electrical difference was between the pulmonary vein and the left atrium, which may help explain why the pulmonary vein region is a common source of AF. The scientists also identified that fiber structure plays an important role in the development of AF. There were directional variations in the conduction of electrical waves along and across the fibers, variations known as anisotropy. The fiber structure in the left atrium is much more organized compared with the complex structures of the pulmonary vein region. The sudden variation in conduction at the junction between the left atrium and the pulmonary vein regions appeared to contribute to the development of AF.

“This study has for the first time identified the individual role of electrical heterogeneity and fiber structure in the initiation and development of AF. It has not previously been possible to study the contribution of the two separately, but using our computational model we’ve been able to clearly see that both electrical heterogeneity and fiber structure need to be taken into consideration when treatment strategies for AF are being devised,” explained lead investigator Prof. Henggui Zhang: “We’re really excited about the potential that our virtual heart opens up for research into this incredibly complex organ. By bringing together physics and biology, we hope to unlock some of the unanswered questions about atrial fibrillation, a condition, which is only going to become more common as people live longer. ”

The next step planned for the team is to find a way to target the electrical conduction in specific regions of the heart to better protect against AF.

The study was published online January 16, 2013, in the Royal Society’s independent journal Interface Focus.

Related Links:
University of Manchester

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.